Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs.
The "foreign drug transparency act" requires a pharmacy benefit manager to maintain and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network. This includes the country of origin of the finished drug product, the country or countries of origin of any active pharmaceutical ingredients, the name and place of business of the original manufacturer of the active pharmaceutical ingredient, and the name and place of business of any packer or distributor, if applicable.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.